Biotie Therapies Corp. announces change in the number of votes relating to its shares

TURKU, 16-3-2015 — /EuropaWire/ — Biotie Therapies Corp. (“Biotie” or the “Company”) has conveyed Biotie shares held as treasury shares, that were issued on 17 December 2014, pursuant to the Equity Incentive Plan 2011 (the “Plan”) as follows:

Shares conveyed Cumulative shares conveyed since
17 December  2014
Remaining shares to be conveyed
 300,000 1,576,875 870,500

The second vesting period of the Equity Incentive Plan 2011 ended on 5 January 2015, after which the Company’s shares shall be delivered to employees on the basis of the granted share units. It was resolved pursuant to the authorization of the Annual General Meeting of the Shareholders held on 3 April 2014 to issue 300,000 existing treasury shares to the employees without consideration for the purposes of remunerating the employees pursuant to the terms and conditions of the Equity Incentive Plan 2011 and thus, there is an especially weighty financial reason to derogate from the pre-emptive right of the shareholders, as referred to in Chapter 9 Section 4(1) of the Companies Act (624/2006, as amended). Due to share issues already made pursuant to the Equity Incentive Plan 2011, forfeitures and some of the instruments based on the plan having been left unallocated, a maximum of 945,000 shares may still be issued pursuant to the Equity Incentive Plan 2011.

The conveyed shares previously held as treasury shares have not carried any voting rights. The conveyance does not affect the number of registered shares. After the conveyances the changes are as follows:

Increase in number of outstanding shares Total amount of
voting rights
Number of the
Company’s shares held
by the Group
Total number
of registered
300,000 452,272,890 3,695,284 455,968,174

Biotie Therapies Corp.

Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail:



Comments are closed.